Vident Investment Advisory, LLC Agenus Inc Transaction History

Vident Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.45 - $2.95 $14,469 - $29,438	-9,979 Reduced 3.33%	289,376 $439,000
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $604,697 - $972,903	299,355 New	299,355 $718,000
Q2 2018 Aug 14, 2018	SELL	$2.26 - $4.65 $1.1 Million - $2.25 Million	-484,930 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$3.51 - $6.04 $457,121 - $786,613	130,234 Added 36.72%	484,930 $2.1 Million
Q4 2017 Feb 15, 2018	BUY	$3.26 - $4.78 $54,605 - $80,065	16,750 Added 4.96%	354,696 $1.16 Million
Q3 2017 Nov 14, 2017	BUY	$3.48 - $4.44 $1.18 Million - $1.5 Million	337,946	337,946 $1.49 Million

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.